Share
Photo: (Photo : VINCENZO PINTO/AFP via Getty Images)
All 50 mothers from Seattle, who were part of a study on a concerning trend, were found to have breast milk containing toxic forever chemicals or PFAS (per- and polyfluoroalkyl substances).
Researchers from Seattle Children s Research Institute, the University of Washington, and Indiana University, detected the chemicals in the mothers breast milk amid presumptions that PFAS use is on the rise. The findings confirmed the scientists worst fears: PFAS builds up in human bodies and brings more potential harm to children.
The Seattle moms who volunteered to have their breast milk tested for PFAS showed levels of toxic forever chemicals that have been described as unsafe. The experts detected nine current-use compounds and 39 other variants, which are understood to be phased-out PFAS.
Clinical ethics pediatrics case based textbook | Pediatrics and child health
cambridge.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cambridge.org Daily Mail and Mail on Sunday newspapers.
PEMCO Mutual Insurance : Launches Fourth Annual School Supply Drive
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
PEMCO Mutual Insurance Launches Fourth Annual School Supply Drive
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
2021 Grant Recipient Shannon Oda, PhD
2021 Grantee: Shannon Oda, PhD
Seattle Children’s Research Institute, University of Washington
Research Project:
Developing Engineered Proteins to Enhance Adoptive Cell Therapy of PDA
Award: 2021 Pancreatic Cancer Action Network Career Development Award made possible by Linda E. Amuso in memory of Susan A. Lombardi
Award Period: July 1, 2021 – June 30, 2023
Amount: $200,000
Biographical Highlights
After receiving her undergraduate degree at Linfield College, Dr. Oda conducted research at a biotech company in Oregon, with a focus on treating diabetes in a mouse model. She completed her doctorate under the guidance of Raul Torres, PhD, at the University of Colorado Anschutz Medical Campus and National Jewish Health, where she described new immune-based pathways to control tumor progression in mice. Dr. Oda worked as a postdoctoral fellow and Research Associate in the lab of Philip Greenberg, MD, recipient of the 2016 PanCAN Translatio